HANS PPO Agreement 42 signed, 65 To Go
by Jeff Blake, Senior Vice President Member & Community Relations

We continue to promote HANS and our PPO Agreement to our member HTCs and the payer community. In addition, we’ve had several discussions with payers to let them know HANS is a solution for Gene Therapy to direct care and services to HTCs. We now have 42 signed PPO agreements with our HTC members, and we are working with several other member HTCs to increase the number of signed PPO agreements. Imagine if all our member HTCs signed the agreement – we could offer the very best national network of HTCs to payers.

We now have 6 HANS Agreements with Payers that our members that have signed our HANS PPO agreement can participate in. The agreements are with:

These agreements and individual letters of agreements (LOAs) have brought back millions of units to the participating HTCs pharmacy programs which as strengthened the sustainability of the programs. In addition, we continue to work with insurance brokers/consultants, insurance companies, third party administrators (TPAs), self-insured employers, stop-loss/reinsurance carriers, and other payers. Based on these payer relationships, we now have more the 50 active payer opportunities to bring back more business to our member HTCs.

We have accomplished a lot, but there is so much more that we can do. Below is a summary of the results of bringing business back to HTC pharmacy programs since 2018.

The Hemophilia Alliance Team is excited about our efforts with payers to support our members and we look forward to working with more member HTCs to expand our HANS efforts to help you grow your pharmacy business to support your HTCs operations and programs.

If you have not signed a HANS PPO Agreement, now is the perfect time. Please contact a member of the Hemophilia Alliance Team to learn more about HANS or how we can assist in solving your payer issues.